Empagliflozin and linagliptin and NovoSeven RT
Determining the interaction of Empagliflozin and linagliptin and NovoSeven RT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: NovoSeven RT with MixPro (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and linagliptin-NovoSeven RT with MixPro injection
- Empagliflozin and linagliptin-Novothyrox
- Empagliflozin and linagliptin-Noxafil
- Empagliflozin and linagliptin-Noxafil (Posaconazole Delayed-Release Tablets)
- Empagliflozin and linagliptin-Noxafil (Posaconazole Injection)
- Empagliflozin and linagliptin-Noxafil (Posaconazole Oral Suspension)
- NovoSeven RT-Empagliflozin and metformin
- NovoSeven RT-Empagliflozin and Metformin Extended-Release Tablets
- NovoSeven RT-Empagliflozin and Metformin Tablets
- NovoSeven RT-Empliciti
- NovoSeven RT-Emsam
- NovoSeven RT-Emsam Transdermal